Avondale Partners downgraded TrueBlue (NYSE: TBI) from Market Outperform to Underperform with a price target of $15.00 (from $20.00).

For an analyst ratings summary and ratings history on TrueBlue click here. For more ratings news on TrueBlue click here.

Shares of TrueBlue closed at $20.00 yesterday.